4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-049397
Chief Medical Officer sold 12,500 shares at an average $32.89 ($411,159)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-09-02 | Option exercise | +12,500 | $1.58 | $19,688 | 42,277 | D |
| Pang Phillip Chief Medical Officer | 2020-09-02 | Sale | −7,500 | $32.88 | $246,622 | 34,777 | D |
| Pang Phillip Chief Medical Officer | 2020-09-02 | Sale | −5,000 | $32.91 | $164,537 | 29,777 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2020-09-02 | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 62,962 | D | ||
| Open-market sales · 12,500 sh · avg $32.89 · $411,159 | |||||||
Loading xslF345X03/doc4.xml…